International Stem Cell (ISCO) Price to Book (2010 - 2026)

International Stem Cell (ISCO) has reported Price to Book for 17 consecutive years, with 0.36 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book fell 9.43% year-over-year to 0.36 in Q2 2026; TTM through Jun 2026 was 0.36, a 9.43% decrease from a year earlier, with the FY2025 full-year figure at 0.28, down 69.4% from the prior year.
• Price to Book was 0.36 for Q2 2026 at International Stem Cell, down from 0.28 in the prior quarter.
• Over five years, Price to Book peaked at 0.02 in Q3 2022 and troughed at 0.85 in Q1 2022.
• A 5-year average of 0.29 and a median of 0.27 in 2023 frame the typical range for Price to Book.
• Across the five-year window, Price to Book surged 102.53% in 2022 and plunged 1108.52% in 2023, its largest moves.
• Over 5 years, Price to Book stood at 0.32 in 2022, then jumped by 64.02% to 0.11 in 2023, then sank by 42.05% to 0.16 in 2024, then sank by 69.4% to 0.28 in 2025, then plunged by 30.32% to 0.36 in 2026.
• The last three Price to Book figures came in at 0.36 (Q2 2026), 0.28 (Q4 2025), and 0.28 (Q3 2025), per Business Quant data.